| |
Group 1 (n = 138)
|
Group 2 (n = 137)
|
P
|
Group 1 (n = 100)
|
Group 2 (n = 100)
|
P
|
|---|
|
Demographics
|
|
Age (years)
|
56.1 ± 7.8
|
55.2 ± 7.1
|
0.34
|
56 ± 7.2
|
55.3 ± 7
|
0.48
|
|
Male
|
119 (86.2%)
|
113 (82.5%)
|
0.39
|
85 (85%)
|
81 (81%)
|
0.58
|
|
BMI (kg/m2)
|
30.9 (27.8–35.9%)
|
31.1 (27.7–33.6)
|
0.18
|
30.4 (28.4–36.4)
|
31.6 (27.7–34.1)
|
0.53
|
|
BSA (m2)
|
2.03 (1.9–2.1)
|
1.96 (1.89–2.05)
|
0.07
|
2.03 (1.93–2.1)
|
1.97 (1.89–2.01)
|
0.15
|
|
Comorbidities
|
|
DM
|
75 (54.4%)
|
65 (47.8%)
|
0.28
|
54 (54%)
|
47 (47%)
|
0.36
|
|
Hypercholesteremia
|
61 (46.2%)
|
56 (41.5%)
|
0.44
|
44 (44%)
|
40 (40%)
|
0.46
|
|
Hypertension
|
87 (63%)
|
86 (63.2%)
|
0.97
|
63 (63%)
|
61 (61%)
|
0.87
|
|
Hypothyroidism
|
3 (2.2%)
|
1 (0.8%)
|
0.62
|
2 (2%)
|
0
|
0.5
|
|
Renal impairment
|
3 (2.2%)
|
1 (0.8%)
|
0.62
|
0
|
1 (1%)
|
> 0.99
|
|
Respiratory disease
|
1 (0.7%)
|
4 (2.96%)
|
0.21
|
1 (1%)
|
2 (2%)
|
> 0.99
|
|
CVD
|
2 (1.5%)
|
2 (1.5%)
|
> 0.99
|
1 (1%)
|
2 (2%)
|
> 0.99
|
|
PVD
|
3 (2.3%)
|
4 (3%)
|
> 0.99
|
3 (3%)
|
2 (2%)
|
> 0.99
|
|
HF (within 1 year)
|
3 (2.2%)
|
8 (6%)
|
0.13
|
3 (3%)
|
1 (1%)
|
0.63
|
|
Previous MI
| | |
0.93
| | |
0.39
|
|
1 attack
|
41 (30.2%)
|
39 (29.55%)
| |
27 (27%)
|
31 (31%)
| |
|
2 or more
|
12 (8.8%)
|
10 (7.6%)
| |
10 (10%)
|
5 (5%)
| |
|
Previous PCI
|
11 (8%)
|
12 (8.8%)
|
0.81
|
9 (9%)
|
(9%)
|
> 0.99
|
|
Symptoms
|
|
Angina class
| | |
< 0.001
| | |
0.35
|
|
I
|
0
|
2 (1.4%)
| |
0
|
0
| |
|
II
|
14 (10.4%)
|
35 (25.9%)
| |
14 (14%)
|
13 (13%)
| |
|
III
|
122 (88.4%)
|
86 (63.7%)
| |
85 (85%)
|
81 (81%)
| |
|
IV
|
2 (1.5%)
|
12 (8.9%)
| |
1 (1%)
|
6 (6%)
| |
|
NYHA (III/IV)
|
120 (87%)
|
85 (62%)
|
< 0.001
|
84 (84%)
|
75 (75%)
|
0.15
|
|
Investigations:
|
|
Creatinine (mg/dl)
|
1 (0.8–1.2)
|
0.9 (0.8–1.2)
|
0.38
|
1 (0.8–1.1)
|
0.9 (0.8–1.19)
|
0.89
|
|
Bilirubin (mg/dl)
|
0.6 (0.4–0.7)
|
0.6 (0.4–0.9)
|
0.28
|
0.6 (0.4–0.9)
|
0.7 (0.4–0.9)
|
0.12
|
|
EF
| | |
> 0.99
| | |
> 0.99
|
|
Good (> 50%)
|
100 (73.5%)
|
99 (73.9%)
| |
73 (73%)
|
74 (74%)
| |
|
Fair (30–50%)
|
35 (25.7%)
|
34 (25.4%)
| |
24 (24%)
|
23 (23%)
| |
|
Poor (< 30%)
|
1 (0.7%)
|
1 (0.8%)
| |
1 (1%)
|
1 (1%)
| |
|
IV nitrates
|
2 (1.5%)
|
1 (0.8%)
|
> 0.99
|
1 (1%)
|
1 (1%)
|
> 0.99
|
- Continuous data were presented as mean ± SD or median (25th–75th percentiles) and categorical data as numbers and percentages
- BMI body mass index, BSA body surface area, CVD cerebrovascular disease, DM diabetes mellitus, EF ejection fraction, HF heart failure, IV intravenous, NYHA New York Heart Association, PVD peripheral vascular disease
